Author Archive: Special Contributor
I am just going to admit at the outset — I am a complete sucker for the dinner party.
If you’re like most people who work in Louisville, you drive to work everyday – alone.
A clinical trial being conducted at the University of Kentucky is investigating a new treatment strategy for Parkinson’s disease that, if successful, could drastically change future treatment and possibly halt or reverse brain degeneration. UK is the first in the U.S. to conduct the clinical trial.
Only four months ago, we marked the 50th anniversary of the 1963 March on Washington, that seminal moment when the eyes of the nation focused on 250,000 demonstrators in Washington, D.C., and where Dr. Martin Luther King, Jr., delivered his immortal “I Have a Dream” speech.
In another sign of the University of Kentucky’s emergence as one of the top universities in America, a new national ranking has UK among the top producers of U.S. Fulbright Scholars — one of the highest honors a faculty member can receive.